October 5-9, 2025
Dubrovnik, Croatia
| Chairs: | Irina Ramos, AstraZeneca |
|---|---|
| Mark Brower, Merck | |
| Alois Jungbauer, BOKU | |
| K. Brower, Sanofi |
Characterization of integrated BioPAT® Viamass for advanced perfusion process control in Ambr® 250 High Throughput Generation 2, Ellen Lam, Philipp Kaiser, Benjamin Sommer, Frederic Houioua, and Barney Zoro (Abstract and Presentation)
Non-Capture Antibody Purification (NCAP) a cost-effective & continuous process, Sravan Pandalaneni, Anna Hermanowska, Razwan Hanif, Nicola Roberts, Mari Spitali, and Chat Zang (Abstract)
Monitoring antibody titer in high cell density perfusion process with miniaturized nanoplasmonic sensor, Maxime Hervé; Fernanda Rebellato; Andreas Castan; Bruno Cavallini, Servier; Erik Martinsson; Murielles Verges; and Véronique Chotteau (Abstract)
Scalable solutions in continuous bioprocessing: Evaluating SP-TFF devices for mAbs, Martin Leuthold, Lukas Kalbhenn, Martine Barros, Florian Mieth, and Jannes Carow (Abstract)
Bioprocess intensification and optimization using macroscopic predictive models of cell culture processes, Neil Kearney, Dr. Bassem Ben Yahia, Mareike Harmsen, An-vy Tran, Gwendal Gränicher, Boris Fessler, and Elmar Heinzle (Abstract)
Protein A EBA, the modern solution to Mab capture from continuous chromatography systems, Neil Watson and Curtis Phippen (Abstract)
Building the business case for continuous manufacturing in biologics, a strategic framework for assessing, comparing, and justifying continuous bioprocessing investments, Richard Steiner and Clifford Rossi (Abstract)
A novel single-use perfusion bioreactor without a mixing impeller that operates with reduced shear and lower cost 1, John Benson (Abstract)
Predicting the environmental footprint of continuous mAb processes, Felix Dieringer and Alois Jungbauer (Abstract)
EnzeneX™ 2.0 and the power of Fully-Connected Continuous Manufacturing™: Driving down mAb costs to $40/gram, Arindam Chakraborty (Abstract)
Plasmid DNA (pDNA) production for gene-based therapeutics: Overcoming downstream bottlenecks with next-generation monolithic QA IEX chromatography media, Scott M. Wheelwright (Abstract)
Intensified high-density perfused batch: Achieving 100g/L productivity in continuous upstream processing, Frederic Houioua (Abstract)
Advanced lentivirus production: Insights from cell retention filter-based perfusion process for scalable and cost-efficient manufacturing, Keen Chung, Riaj Mahamud, and René Gantier (Abstract)
Intensified perfusion culture enabling high productivity, good product quality, and low manufacturing costs, Hang Zhou, Mingyue Fang, and Hang Zho (Abstract)